p300/CBP inhibition enhances the efficacy of programmed death-ligand 1 blockade treatment in prostate cancer - Concepedia

Concepedia

Publication | Open Access

p300/CBP inhibition enhances the efficacy of programmed death-ligand 1 blockade treatment in prostate cancer

DOI Full Paper Access

110

Citations

25

References

2020

Year

Jinghui Liu, Daheng He, Lijun Cheng, Changkun Huang, Yanquan Zhang, Xiongjian Rao, Yifan Kong, Chaohao Li, Zhuangzhuang Zhang, Jinpeng Liu,

UrologyOncologyMedicineP300/cbp InhibitionImmune Checkpoint InhibitorPharmacotherapyAnti-cancer AgentCancer TreatmentProstatic DiseasePharmacologyProgrammed Death-ligand 1

References

	Year	Citations

Page 1

Page 1